(6bR,10aR)-3-Methyl-2,3,6b,7,8,9,10,10a-octahydro-1H-pyrido[3',4':4,5]pyrrolo[1,2,3-de]quinoxaline(CAS: 313368-85-3)

This compound is a crystalline solid with a molecular weight of approximately 280.33 g/mol. It has a low solubility in water but is soluble in organic solvents like methanol and dichloromethane. Chemically, it is unstable under strong acidic or basic conditions and reacts with nucleophiles. It is also prone to thermal degradation and polymerization under high temperatures.

This compound is synthesized via a multi-step process starting from quinoxaline. Common methods include condensation and cyclization reactions. The key steps involve the formation of a 2,3-dicarbonyl intermediate, followed by cyclization and methylation. The reaction conditions and catalysts can vary, but the overall yield is around 70-80%.

This compound finds applications in the pharmaceutical industry, where it is used as a precursor for drug synthesis. It is also utilized in the semiconductor industry for doping purposes. Additionally, it has potential applications in the polymer industry for the development of novel materials and in the sensor industry for functional polymers.

When handling this compound, it is essential to wear appropriate personal protective equipment (PPE), including gloves, goggles, and a lab coat. Handle it in a well-ventilated fume hood to minimize exposure to air. Store it in a cool, dry place, away from heat and direct sunlight. In case of a spill, immediately use appropriate cleanup materials and follow standard safety protocols. For detailed safety information, refer to the SDS (Safety Data Sheet).